Cancer-killing cells controlled by epigenetic process, new study shows
For the first time, a new study from the Keck School of Medicine of USC (home of the USC Norris Comprehensive Cancer Center) has described how natural killer (NK) cells in the human body, which can kill and contain viruses and cancerous tumors, can be manipulated by epigenetics. The discovery, detailed in the Proceedings of the National Academy of Sciences, paves the way for developing more effective cancer drugs.
Among the research institutions NCI funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.